Scarica l'app Stockscreener
1.08
0.92%
-0.01
Precedente Chiudi:
$1.09
Aprire:
$1.11
Volume 24 ore:
367.80K
Relative Volume:
0.47
Capitalizzazione di mercato:
$34.62M
Reddito:
-
Utile/perdita netta:
$-42.37M
Rapporto P/E:
-1.0107
EPS:
-1.0686
Flusso di cassa netto:
$-34.94M
1 W Prestazione:
-10.74%
1M Prestazione:
-16.92%
6M Prestazione:
-47.32%
1 anno Prestazione:
-68.05%
Intervallo 1D:
$1.04
$1.13
Intervallo di 1 settimana:
$1.04
$1.27
Portata 52W:
$1.04
$5.75
Skye Bioscience Inc Stock (SKYE) Company Profile
Nome
Skye Bioscience Inc
Settore
Industria
Telefono
(858) 410-0266
Indirizzo
11250 EL CAMINO REAL, SUITE 100, SAN DIEGO
Confronta SKYE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SKYE
Skye Bioscience Inc.
|
3.10 | 12.89M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.49 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
4.17 | 303.77M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
SHMD
Schmid Group N V
|
5.04 | 221.34M | 0 | 0 | 0 | 0.00 |
|
DAVEW
Dave Inc
|
0.67 | 0 | 0 | 0 | 0 | 0.00 |
|
DWLD
Davis Select Worldwide ETF
|
46.76 | 0 | 0 | 0 | 0 | 0.00 |
Skye Bioscience Inc Stock (SKYE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2025-10-06 | Downgrade | Craig Hallum | Buy → Hold |
| 2025-08-15 | Iniziato | Evercore ISI | Outperform |
| 2025-02-28 | Iniziato | William Blair | Outperform |
| 2024-09-30 | Iniziato | Scotiabank | Sector Outperform |
| 2024-09-10 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-07-09 | Iniziato | Craig Hallum | Buy |
| 2024-05-23 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-04-12 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Skye Bioscience Inc Borsa (SKYE) Ultime notizie
Bragar Eagel & Squire, P.C. Urges DeFi, Skye Bioscience, - GlobeNewswire
Class Action Lawsuit Filed Against Skye Bioscience, Inc. (SKYE)Recover LossesContact Levi & Korsinsky Before January 16, 2026 - ACCESS Newswire
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit - PR Newswire
Kuehn Law Encourages Investors of Skye Bioscience, Inc. to Contact Law Firm - TMX Newsfile
SKYE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Skye Bioscience, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
Portnoy Law Firm Announces Class Action on Behalf of Skye Bioscience, Inc. Investors - GlobeNewswire
Join Class Action to Recover Losses from Skye Bioscience, Inc. (SKYE)Contact Levi & Korsinsky Before January 16, 2026 - ACCESS Newswire
The Gross Law Firm Reminds Skye Bioscience, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026SKYE - PR Newswire
Investors Urged to Contact Levi & Korsinsky for Information Before January 16, 2026 – Skye Bioscience, Inc. (SKYE) - ACCESS Newswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience - marketscreener.com
Levi & Korsinsky Notifies Skye Bioscience, Inc. Investors of a C - GuruFocus
SKYE STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Skye Bioscience, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Is Skye Bioscience Inc a good long term investmentGlobal Market Influence & Create Your Free Watchlist Instantly - earlytimes.in
Class Action Alert: Levi & Korsinsky Reminds Skye Bioscience, Inc. (SKYE) Investors of January 16, 2026 Deadline - ACCESS Newswire
SKYE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
SKYE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Skye Bioscience, Inc. to Contact the Firm Today! - ACCESS Newswire
Lost Money on Skye Bioscience, Inc. (SKYE)? Join Class Action Suit Seeking RecoveryContact The Gross Law Firm - Louisiana First News
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
After-Hours Gainers: Biotech Stocks Climb On Data Anticipation And Momentum Buying - RTTNews
Investors SueWallSt as Skye Bioscience, Inc. Faces Securities Fraud Allegations - ACCESS Newswire
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Se - GuruFocus
Investors SueWallSt as Skye Bioscience, Inc. Faces Securities Fraud Allegations (2025-12-10) - Seeking Alpha
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience - GlobeNewswire
Skye Bioscience, Inc. Sued for Securities Law Violations – - GlobeNewswire
Lost Money on Skye Bioscience, Inc.(SKYE)? Join Class Action Sui - GuruFocus
Lost Money on Skye Bioscience, Inc.(SKYE)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - Sahm
Levi & Korsinsky Helps Retail Investors SueWallSt Over Alleged Fraud by Skye Bioscience, Inc - Stockhouse
January 16, 2026 Deadline: Join Class Action Lawsuit Against Skye Bioscience, Inc. (SKYE)Contact Levi & Korsinsky - ACCESS Newswire
Shareholders that lost money on Skye Bioscience, Inc. (SKYE) Urg - GuruFocus
Shareholders that lost money on Skye Bioscience, Inc. (SKYE) Urged to Join Class ActionContact The Gross Law Firm to Learn More - PR Newswire
Lawsuit DEADLINE: Investors who purchased over $100,000 worth of shares of Skye Bioscience, Inc. (NASDAQ: SKYE) between Nov. 2024 and Oct. 2025 should contact the Shareholders Foundation - PR Newswire
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Skye Bioscience, Inc. Investors to Secure ... - Caledonian Record
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Skye - GlobeNewswire
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Skye Bioscience, Inc. (SKYE) Investors of January 16, 2026 Deadline - ACCESS Newswire
SKYE SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Skye Bioscience, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Will Skye Bioscience Inc. (09R) stock profit from fiscal stimulusQuarterly Portfolio Summary & High Accuracy Buy Signal Tips - Newser
Berger Montague PC Investigating Claims on Behalf of Skye Bioscience, Inc. (NASDAQ: SKYE) Investors After Class Action Filing - Your Wyoming Link
Skye Bioscience, Inc. Class Action: Levi & Korsinsky - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates - GuruFocus
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience - PR Newswire
Shareholders of Skye Bioscience, Inc. Should Contact The Gross L - GuruFocus
Shareholders of Skye Bioscience, Inc. Should Contact The Gross Law Firm Before January 16, 2026 to Discuss Your RightsSKYE - PR Newswire
Will Skye Bioscience Inc. (09R) stock gain from lower interest ratesJuly 2025 Technicals & Long-Term Safe Investment Ideas - Newser
SueWallSt With Us: Levi & Korsinsky Notifies Shareholders of Class Action Against Skye Bioscience, Inc - ACCESS Newswire
Investors in Skye Bioscience, Inc. Should Contact Levi & Korsinsky Before January 16, 2026 to Discuss Your RightsSKYE - WV News
SKYE INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience - GlobeNewswire
You might want to take a look at Skye Bioscience Inc (SKYE) now - Setenews
SKYE Class Action Reminder: Skye Bioscience, Inc. Stockholders Should Contact Robbins LLP for Information About the Securities Class Action Lawsuit - Lelezard
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionSKYE - TMX Newsfile
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience - Newsfile
SKYE SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Skye Bioscience, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Skye Bioscience Inc Azioni (SKYE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Skye Bioscience Inc Azioni (SKYE) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Schwab Andrew J. | Director |
Aug 21 '25 |
Sale |
3.57 |
60,956 |
217,613 |
63,963 |
| 5AM Partners VII, LLC | 10% Owner |
Aug 22 '25 |
Sale |
3.42 |
170,449 |
582,936 |
57,493 |
| 5AM Partners VII, LLC | 10% Owner |
Aug 21 '25 |
Sale |
3.57 |
60,956 |
217,613 |
63,963 |
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):